Scholars@Duke
Gabriel Torrealba-Acosta

Gabriel Torrealba-Acosta

Assistant Professor of Neurology
Neurology, Neurocritical Care
gabriel.torrealba-acosta@duke.edu
Department of Neurology, Box 2900, Duke University Medical Center, Durham, NC 27710

Scholarly Works - Conferences

2268-P: Distinct Risk Profiles for Cardiovascular and Cancer Mortality in People with Diabetes from the UK Biobank

Conference Diabetes · June 5, 2026 Introduction and Objective: Cardiovascular disease and cancer are leading causes of death in people with diabetes. We aimed to compare their associated risk profiles.Methods: We studied 28,043 adults with diabete ... Full text Cite

2266-P: Multimorbidity Phenotypes in Diabetes and Their Association with All-Cause Mortality: A Latent Class Analysis in the UK Biobank

Conference Diabetes · June 5, 2026 Introduction and Objective: Multimorbidity is common in diabetes and affects long-term survival. We aimed to identify multimorbidity phenotypes and their link to 10-year all-cause mortality.Methods: We applied la ... Full text Cite

2265-P: Multimorbidity Phenotypes in Diabetes and Their Association with 10-Year Dementia Risk: A Latent Class Analysis in the UK Biobank

Conference Diabetes · June 5, 2026 Introduction and Objective: Multimorbidity is common in diabetes and may impact cognitive risk. We used latent class analysis to identify multimorbidity phenotypes and their association with incident dementia.Met ... Full text Cite

2267-P: Shared Proteomic Pathways Linking Cardiovascular Disease and Cancer in People with Diabetes: A UK Biobank Cohort Analysis

Conference Diabetes · June 5, 2026 Introduction and Objective: People with diabetes frequently develop cardiovascular (CV) disease and cancer, but the shared biological pathways are unclear. We compared their proteomic signatures.Methods: We analy ... Full text Cite

1263-P: Determinants of Cardiovascular Risk Factors in the Aging Costa Rican Population—Insights from an Ordered Logistic Regression Model in the Costa Rican Longevity and Healthy Aging Study

Conference Diabetes · June 14, 2024 Introduction: The Costa Rican Longevity and Healthy Aging Study (CRELES), initiated in 2005, captures the health and lifestyle of elderly Costa Ricans with survival data up to 2019. We explored the association between sociodemographic and clinical ... Full text Cite

54-PUB: Exploring Categories of Controlled Cardiovascular Risk Factors in the Elderly—Insights from the Costa Rican Longevity and Healthy Aging Study

Conference Diabetes · June 14, 2024 Introduction: The prospective cohort Costa Rican Longevity and Healthy Aging Study (CRELES) offers comprehensive data on the lifestyle of elderly Costa Ricans enrolled in 2005, with survival status up to 2019. We aimed to describe the characteristi ... Full text Cite

1262-P: Effect of Cardiovascular Risk Factor Control on Mortality in Older Adults—Findings from the Costa Rican Longevity and Healthy Aging Study

Conference Diabetes · June 14, 2024 Introduction: The Costa Rican Longevity and Healthy Aging Study prospective cohort examined older adults' health status in Costa Rica. We investigated the influence of goal attainment on controlling cardiovascular risk factors (CVRFs): BMI, A1C, ex ... Full text Cite

Abstract WMP9: Favorable Mechanical Thrombectomy Outcomes From The Latin American Stroke Registry (lase) And Resilient Trial Compared To A 90-day Functional And Mortality Predictive Model.

Conference Stroke · February 2023 Introduction: Except for RESILIENT, there is a paucity of randomized controlled trials (RCTs) for stroke from Latin America (LA), home to growing stroke burden. Comparison between stroke population ty ... Full text Cite

Abstract WP14: A Patient-level Data Euclidean-matched Analysis Of Reperfusion Therapies In Acute Ischemic Stroke From The Latin American Stroke Registry (lase)

Conference Stroke · February 2023 Introduction: As acute stroke therapies expand to less well-resourced regions, it is imperative to study real-world data to assess outcomes and the quality of stroke care. The present study analyzes c ... Full text Cite

Abstract P17: Outcomes After Thrombolysis for Ischemic Stroke in Costa Rica Compare Favorably With International Cohorts

Conference Stroke · March 2021 Background: More than 70% of strokes occur in resource-poor countries. Outcomes are often not well documented. rt-PA for acute ischemic stroke was approved in 2012 for use in Costa Rica (CR). A hub an ... Full text Cite

Preliminary effects of real-world factors on the recovery and exploitation of forensic impurity profiles of a nerve-agent simulant from office media.

Conference J Chromatogr A · December 28, 2012 Dimethyl methylphosphonate (DMMP) was used as a chemical threat agent (CTA) simulant for a first look at the effects of real-world factors on the recovery and exploitation of a CTA's impurity profile for source matching. Four stocks of DMMP having differen ... Full text Link to item Cite